Cargando…

Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts

Low- and middle-income countries need to consider economic issues such as cost-effectiveness, affordability and sustainability before introducing a program for human papillomavirus (HPV) vaccination. However, many such countries lack the technical capacity and data to conduct their own analyses. Ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jit, Mark, Levin, Carol, Brisson, Marc, Levin, Ann, Resch, Stephen, Berkhof, Johannes, Kim, Jane, Hutubessy, Raymond
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582485/ https://www.ncbi.nlm.nih.gov/pubmed/23363734 http://dx.doi.org/10.1186/1741-7015-11-23

Ejemplares similares

Q&A - Economic analyses for vaccine introduction decisions in low- and middle- income countries
por: Hutubessy, Raymond
Publicado: (2013)

Costs of Introducing and Delivering HPV Vaccines in Low and Lower Middle Income Countries: Inputs for GAVI Policy on Introduction Grant Support to Countries
por: Levin, Ann, et al.
Publicado: (2014)

Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
por: Levin, Ann, et al.
Publicado: (2023)

Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries
por: Deogaonkar, Rohan, et al.
Publicado: (2012)

Stakeholders’ perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods study
por: van der Putten, Ingeborg M, et al.
Publicado: (2015)

Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework
por: Carvalho, Natalie, et al.
Publicado: (2017)

WHO-led consensus statement on vaccine delivery costing: process, methods, and findings
por: Levin, Ann, et al.
Publicado: (2022)

HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control
por: Canfell, Karen, et al.
Publicado: (2019)

Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis
por: Drolet, Mélanie, et al.
Publicado: (2021)

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models
por: Jit, Mark, et al.
Publicado: (2011)

Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: a mathematical modelling analysis
por: Bénard, Élodie, et al.
Publicado: (2023)

Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?
por: Jit, Mark, et al.
Publicado: (2016)

Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries
por: Brisson, Marc, et al.
Publicado: (2020)

Consensus-based guidance for conducting and reporting multi-analyst studies
por: Aczel, Balazs, et al.
Publicado: (2021)

Measurement of benefits in economic evaluations of nutrition interventions in low‐ and middle‐income countries: A systematic review
por: Wun, Jolene, et al.
Publicado: (2022)

Evaluation of VSW "Vacuum Analyst" residual gas analyser
por: Hoekemeijer, F
Publicado: (1983)

Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community
por: Ultsch, Bernhard, et al.
Publicado: (2015)

Economic Returns to Investment in AIDS Treatment in Low and Middle Income Countries
por: Resch, Stephen, et al.
Publicado: (2011)

Public Analysts
Publicado: (1878)

Forecasting Stock Price Trends by Analyzing Economic Reports With Analyst Profiles
por: Suzuki, Masahiro, et al.
Publicado: (2022)

A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool
por: Hutubessy, Raymond, et al.
Publicado: (2012)

Commentary: The analyst and automation
Publicado: (1979)

An introduction to independence for analysts
por: Dales, H G, et al.
Publicado: (1987)

The Enterprise Business Analyst
por: Hass, Kathleen
Publicado: (2011)

Drug Analysts' Conference
Publicado: (1954)

The broader economic impact of vaccination: reviewing and appraising the strength of evidence
por: Jit, Mark, et al.
Publicado: (2015)

What We Do Not Know About the Costs of Immunization Programs in Low- and Middle-Income Countries
por: Portnoy, Allison, et al.
Publicado: (2021)

The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study
por: Clark, Rebecca A, et al.
Publicado: (2023)

Unlocking financial data: a practical guide to technology for equity and fixed income analysts
por: Pauley, Justin
Publicado: (2017)

Silica Hydride: A Separation Material Every Analyst Should Know About
por: Pesek, Joseph J., et al.
Publicado: (2021)

Ranking 93 health interventions for low- and middle-income countries by cost-effectiveness
por: Horton, Susan, et al.
Publicado: (2017)

Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis
por: Bénard, Élodie, et al.
Publicado: (2022)

Economic analyses of breast cancer control in low- and middle-income countries: a systematic review
por: Zelle, Sten G, et al.
Publicado: (2013)

Economic Evaluations of HPV Vaccination in Targeted Regions of Low- and Middle-Income Countries: A Systematic Review of Modelling Studies
por: Frianto, Dedy, et al.
Publicado: (2022)

The Excel® Analyst's Guide to Access®
por: Alexander, Michael
Publicado: (2010)

Integrating economic and health evidence to inform Covid-19 policy in low- and middle- income countries
por: Vassall, Anna, et al.
Publicado: (2022)

Big data analystics : Toolsand Technology for Effective Planning /
Publicado: (2018)

Impact and cost-effectiveness of measles vaccination through microarray patches in 70 low-income and middle-income countries: mathematical modelling and early-stage economic evaluation
por: Fu, Han, et al.
Publicado: (2023)

Programme costs in the economic evaluation of health interventions
por: Johns, Benjamin, et al.
Publicado: (2003)

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study
por: Portnoy, Allison, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kp60fa6h216ei57ergapbvlfg5